• GluN2A/B Regulation of Gap Junctions in TMJ Inflammatory All

  2026-05-21

  This study reveals that NMDAR subunits GluN2A and GluN2B distinctly regulate connexins and pannexins in the trigeminal ganglion, driving orofacial inflammatory allodynia during TMJ inflammation. The findings clarify molecular mechanisms underlying peripheral sensitization and offer new therapeutic targets for chronic pain associated with TMJ disorders.

• PTX3 Protects Against Glucocorticoid-Induced ONFH via TLR4/N

  2026-05-21

  This study uncovers a mechanistic link between pentraxin 3 (PTX3) and the TLR4/NF-κB-FGF21 signaling axis in mitigating glucocorticoid-induced osteonecrosis of the femoral head (ONFH). The findings offer a new therapeutic perspective on bone preservation under glucocorticoid stress, highlighting the importance of innate immune modulation.

• Carvedilol Phosphate in Ischemia–Reperfusion Injury Models

  2026-05-20

  Carvedilol Phosphate unlocks direct control over beta-adrenergic signaling in hepatic and cardiac ischemia–reperfusion injury (IRI) models. This guide details protocol advancements, practical troubleshooting, and leverages the latest mechanistic insights to accelerate high-impact cardiovascular pharmacology research.

• UTP Solution: Precision in RNA Synthesis and Metabolic Assay

  2026-05-20

  UTP Solution (100 mM) empowers RNA transcription, amplification, and metabolic research with unmatched purity—maximizing sensitivity and reproducibility even in DNase/RNase-sensitive settings. This APExBIO reagent unlocks advanced workflows, from single-cell epigenetic studies to high-throughput siRNA synthesis, with clear troubleshooting pathways for superior results.

• Gramine Induces Ferroptosis via CUL3–MTDH Axis in TNBC Model

  2026-05-19

  The referenced study uncovers how Gramine, a natural indole alkaloid, inhibits triple-negative breast cancer (TNBC) growth by inducing ferroptosis through direct modulation of the CUL3–MTDH ubiquitination pathway. This mechanistic insight positions Gramine as a promising research tool for dissecting ferroptosis and ubiquitination dynamics in aggressive cancer subtypes.

• Ruxolitinib Phosphate Triggers Apoptosis and Pyroptosis in A

  2026-05-19

  This study demonstrates that Ruxolitinib phosphate (INCB018424) induces both apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma (ATC) by inhibiting DRP1-mediated mitochondrial fission through JAK1/2-STAT3 pathway suppression. The findings provide new mechanistic insight into JAK/STAT signaling pathway modulation and highlight a potential therapeutic direction for aggressive thyroid cancers.

• Tamoxifen as a Selective Estrogen Receptor Modulator: Advanc

  2026-05-18

  Tamoxifen, a selective estrogen receptor modulator, is indispensable in gene knockout and cancer biology research. This article unpacks protocol refinements, troubleshooting, and the pivotal impact of recent findings on dose-dependent developmental effects, guiding researchers toward reproducible, high-fidelity results.

• Tofacitinib Reverses GM-CSF-Induced Mitochondrial Dysfunctio

  2026-05-18

  This article examines how tofacitinib (CP-690550) uniquely reverses inflammation and mitochondrial dysregulation in GM-CSF-reprogrammed macrophages from rheumatoid arthritis (RA) patients. By selectively inhibiting JAK/STAT signaling—particularly STAT5—this approach corrects metabolic and phenotypic abnormalities not addressed by anti-TNF, anti-IL6R, or metabolic-targeted therapies, highlighting new directions for immune modulation research.

• Stiripentol as an LDH Inhibitor: Metabolic Epigenetics in Fo

  2026-05-17

  Explore Stiripentol's role as a novel LDH inhibitor in metabolic epigenetics and advanced epilepsy research. This article uniquely connects lactate metabolism, histone lactylation, and experimental protocols for breakthrough insights.

• Degarelix Acetate: Potent GnRH Receptor Antagonist for Prost

  2026-05-16

  Degarelix acetate is a highly selective GnRH receptor antagonist approved for advanced prostate cancer. It delivers rapid, sustained suppression of pituitary hormones and serum testosterone, making it a benchmark tool in hormone secretion inhibition research. Clinical and preclinical data confirm its efficacy, specificity, and safety profile.

• Tetracycline in Precision Ribosome Assays: Mechanistic Depth

  2026-05-15

  Explore how Tetracycline, a broad-spectrum polyketide antibiotic, empowers advanced ribosomal function research. This in-depth article provides unique mechanistic analysis, protocol insights, and new guidance for optimizing microbiological experiments.

• 4-Hydroxytamoxifen: Technical Protocols for Laboratory Resea

  2026-05-15

  4-Hydroxytamoxifen (SKU B6167) is a high-purity estrogen receptor modulator optimized for controlled studies in breast cancer, prostate cancer, and cardiac myocyte research. It solves solubility and reproducibility issues commonly encountered in aqueous or ethanol-based workflows by providing reliable DMSO compatibility. Use is not recommended in protocols requiring water or ethanol solubility.

• CDK4 Regulates 4E-BP1 to Drive Cap-Dependent Translation in

  2026-05-14

  This study reveals cyclin-dependent kinase 4 (CDK4) as a direct regulator of the translational repressor 4E-BP1, facilitating cap-dependent translation during the mitosis–G1 transition. The findings provide new mechanistic insight into cell cycle-dependent translational control and have implications for understanding drug resistance and targeted cancer therapy.

• Mitochondrial Permeability Transition Pore Assay Kit: Applie

  2026-05-14

  Unlock sensitive and reproducible mitochondrial permeability assays with the APExBIO Mitochondrial Permeability Transition Pore Assay Kit. Explore advanced workflows, troubleshooting strategies, and translational insights drawn from cutting-edge research in cell death and mitochondrial dysfunction.

• Tofacitinib (CP-690550) Workflows for Immune Modulation Rese

  2026-05-13

  Tofacitinib (CP-690550) enables precise inhibition of JAK/STAT signaling, uniquely reversing GM-CSF-driven inflammation and mitochondrial dysfunction in immune cell models. This article translates cutting-edge findings into actionable protocols, troubleshooting guidance, and comparative advantages for advanced immune modulation research.

14782 records 1/986 page Next 12345 下5页 Last page